| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 01/29/2008 | CA2142998C N-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retroviral protease inhibitors |
| 01/29/2008 | CA2140928C Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/24/2008 | WO2008009613A1 Non-nucleoside reverse transcriptase inhibitors |
| 01/24/2008 | WO2007143014A3 Methods for preparing glutamic acid derivatives and intermediates thereof |
| 01/24/2008 | CA2657723A1 Non-nucleoside reverse transcriptase inhibitors |
| 01/23/2008 | EP1879895A1 Enzyme inhibitors |
| 01/23/2008 | EP1633354B1 N-(((((1,3-thiazol-2-yl)amino)carbonyl)phenyl)sulfonyl)phenylalanine derivatives and related compounds for the treatment of diabetes |
| 01/23/2008 | CN100363341C Opticall activity N-propargyl sulfamide monomer and related polymer and its preparation method |
| 01/22/2008 | US7321001 carboxylic acid derivatives which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer |
| 01/22/2008 | US7320983 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
| 01/22/2008 | CA2374362C Urea derivatives as hiv aspartyl protease inhibitors |
| 01/17/2008 | WO2008007780A1 Pentadienamide derivative |
| 01/17/2008 | US20080015256 Tetralin and indane derivatives and uses thereof |
| 01/17/2008 | US20080015208 3-Fluoro-N-(5-ureidomethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-benzenesulfonamide; serotonin receptors 5-HT6 and 5-HT2A ligand; neurodegenerative disorders; antidepressant, anxiolytic agent; Parkinson's disease, Huntington's disease, manic depression, psychoses, epilepsy, obesity, drug abuse |
| 01/17/2008 | US20080015180 Methods and compositions for treating amyloid-related diseases |
| 01/17/2008 | CA2658097A1 Pentadienamide derivatives |
| 01/16/2008 | EP1567486B1 Bis-aryl sulfonamides |
| 01/16/2008 | EP1204626B1 Ether compounds, compositions, and uses thereof |
| 01/16/2008 | CN101107222A Substituted aminomethylene sulphonamides, production and use thereof as medicaments |
| 01/16/2008 | CN101104598A Process for preparing trans-4-amino-1-cyclohexanecarboxilic acid derivatives |
| 01/15/2008 | US7319170 Hyperglycemia that is symptomatic of type II diabetes, as well as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes; N-[(cyclohexylamino)carbonyl]-4-{3-[4-(4-fluorophenoxy)-2-propylphenoxy]propoxy}benzenesulfonamide |
| 01/15/2008 | US7319163 N-[3,5-Dibromo-4-(3-bromobenzyloxy)benzoyl]benzenesulphonamide for example; cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyroidism |
| 01/15/2008 | US7319111 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists |
| 01/10/2008 | WO2008004673A1 Cycloalkene derivatives, process for production of the derivatives, and use of the same |
| 01/10/2008 | WO2007135080A3 (2r)-2-[(4-sulfonyl)aminophenyl]propanamides and pharmaceutical compositions containing them |
| 01/10/2008 | US20080009639 Preparation of oseltamivir phosphate (Tamiflu) and intermediates starting from D-glucose or D-xylose |
| 01/10/2008 | US20080009524 Such as 5'-(1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-2'-methyl-N-(methylsulfonyl)biphenyl-3-carboxamide; cystic fibrosis transmembrane conductance regulator disorders |
| 01/09/2008 | EP1402890B1 Sulfonamide derivatives |
| 01/09/2008 | CN101102997A Sulphonylated diphenylethylenediamines, method for their preparation and use in trasfer hydrogenation catalysis |
| 01/08/2008 | US7317111 derivatives of hydroxy-pyrene trisulphonic and disulphonic acids |
| 01/08/2008 | CA2334298C Neuropeptide y5 receptor antagonists |
| 01/03/2008 | WO2008000969A1 Novel naphthalenic derivatives, method for the preparation thereof, and pharmaceutical compositions containing same |
| 01/03/2008 | US20080004415 Non-linear optically active molecules, their synthesis, and use |
| 01/03/2008 | US20080004256 Amidinophenylalanine Derivatives as Thrombin Inhibitors |
| 01/03/2008 | US20080004251 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor |
| 01/03/2008 | US20080003290 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
| 01/03/2008 | DE102006023649A1 Hydrophobe ionische Flüssigkeiten Hydrophobic Ionic Liquids |
| 01/02/2008 | EP1871739A1 Compounds which inhibit beta-secretase activity and methods of use thereof |
| 01/02/2008 | EP1268404B1 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 01/02/2008 | EP1263716B1 Amino acid derivatives as hiv aspartyl protease inhibitors |
| 01/02/2008 | EP1174417B1 Fluorine compounds and water- and oil-repellant compositions |
| 01/02/2008 | CN100358865C Sulfonamide phenylalkylamine compound, its preparation method and application |
| 01/01/2008 | US7314950 Sulfinating a trans-alkyl 4-aminocyclohexanecarboxylate (formed by iminating the cis-analog with a benzaldehyde and hydrolyzing the product) with an alkanesulfinyl chloride and oxidizing the product to form an alkyl 4-alkylsulfonamidocyclohexanecarboxylate, which then may be hydrolyzed |
| 01/01/2008 | US7314889 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 01/01/2008 | US7314888 2-{5-[(2,4-diisobutoxyphenyl)(hydroxy)methyl]-2-isobutoxyphenyl}-acetic acid; inhibits the activity of transcription factor AP-1 |
| 01/01/2008 | US7314874 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide;modified amidine elements of high potency in vitro, excellent pharmacological and pharmaceutical properties in vivo |
| 12/27/2007 | WO2007147762A1 Arylsulfonamidyl tetralin derivatives and uses thereof |
| 12/27/2007 | WO2006065385A8 Fluorochemical diesters as repellent polymer melt additives |
| 12/27/2007 | US20070299117 Hydroxypropylaimines |
| 12/27/2007 | US20070299114 Biaryl Derivatives |
| 12/27/2007 | US20070299107 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 12/27/2007 | CA2655524A1 Arylsulfonamidyl tetralin derivatives and uses thereof |
| 12/26/2007 | EP1868989A2 Inhibitors of neurotrypsin and determination thereof |
| 12/26/2007 | EP1868986A1 Tetrahydronaphthalene derivatives method for the production and the use thereof in the form of antiphlogistics |
| 12/26/2007 | EP1597248B1 Sulfonamide derivatives as ppar modulators |
| 12/26/2007 | EP1556390A4 Functionalized ionic liquids, and methods of use thereof |
| 12/26/2007 | EP0804428B1 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 12/26/2007 | CN101094832A Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 12/26/2007 | CN101094829A Novel anthranilic acid derivative or salt thereof |
| 12/26/2007 | CN101092402A New compound in sulfonyl ureas, and medicine use |
| 12/26/2007 | CN100357290C Pesticidal 3-(substituted phenyl)-5-(thienyl or furyl)-1,2,4-triazoles |
| 12/25/2007 | US7312360 Substituted hydroxyethylamines |
| 12/25/2007 | US7312358 Dysmenorrhea; congestive heart failure; liver disorders; vision defects |
| 12/25/2007 | US7312241 Diphenylethylene compounds and uses thereof |
| 12/25/2007 | US7312230 Carboxylic acid derivatives as IP antagonists |
| 12/25/2007 | US7312191 prenylation enzyme inhibitors such as 5,9,13-trimethyl-2-nitrotetradeca-2,8,12-triene, used as anticarcinogenic or antitumor agents |
| 12/25/2007 | US7312177 Thermosensitive recording materials |
| 12/21/2007 | WO2002072068A3 Lipids, lipid compositions, liposomes, and lipoplexes |
| 12/20/2007 | US20070293682 Methods of Preparing Sulfinamides and Sulfoxides |
| 12/20/2007 | US20070293573 Glu2 receptor modulators |
| 12/20/2007 | US20070293547 Compounds and Compositions as Lxr Modulators |
| 12/20/2007 | US20070293495 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine |
| 12/20/2007 | US20070293483 Acetyl 2-hydroxy-1, 3-diaminoalkanes |
| 12/19/2007 | EP1867633A1 Polyamine analogues as therapeutic and diagnostic agents |
| 12/19/2007 | EP1866285A1 1-sulfonyl-piperdine-3-carboxylic acid amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase for the treatment of type ii diabetes mellitus |
| 12/19/2007 | EP1497261B1 Phenethanolamine derivatives |
| 12/19/2007 | EP1370521B1 Formanilide derivatives as beta2-adrenoreceptor agonists |
| 12/19/2007 | EP1115693B9 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 12/19/2007 | CN101090892A Sulphonamide derivatives, their preparation and their therapeutic application |
| 12/19/2007 | CN101090883A Substituted hydroxyethylamines |
| 12/19/2007 | CN100355491C Waterpower liquid |
| 12/18/2007 | US7309721 Aminoalkylphosphonates and related compounds as Edg receptor agonists |
| 12/13/2007 | WO2007143735A2 Polycationic sulfonamides and use thereof |
| 12/13/2007 | WO2007143014A2 Methods for preparing glutamic acid derivatives and intermediates thereof |
| 12/13/2007 | WO2007141423A1 Ppar enhancing derivatives, method for preparing same and therapeutic use thereof |
| 12/13/2007 | WO2007117981A3 Selective hydroxamate based mmp inhibitors |
| 12/13/2007 | US20070287750 Polycationic sulfonamides and use thereof |
| 12/13/2007 | US20070287710 Piperidinediyl-containing sulfonamide; NPY Y5 receptor antagonist activity; antiobesity agent or anorectic agent |
| 12/13/2007 | CA2653463A1 Methods for preparing glutamic acid derivatives and intermediates thereof |
| 12/12/2007 | EP1864981A1 Thrombopoietin mimetics |
| 12/12/2007 | EP1863804A1 Inhibitors of histone deacetylase |
| 12/12/2007 | EP1237859B1 Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia |
| 12/12/2007 | CN101087771A Substituted N-sulfonylaminobenzyl-2-phenoxyacetamide compounds |
| 12/12/2007 | CN101087754A Novel cyclohexane derivatives |
| 12/12/2007 | CN100354981C Composition for polyelectrolytes, polyelectrolytes, electrical double layer capacitors and nonaqueous electrolyte secondary cells |
| 12/12/2007 | CN100354253C 5,8-menadiol diacetate derivatives and their preparing process and use |
| 12/11/2007 | US7307191 Organic peroxyacid precursors |
| 12/06/2007 | WO2007138069A1 Lysine related derivatives as hiv aspartyl protease inhibitors |
| 12/06/2007 | WO2007107828A3 Amine derivatives |
| 12/06/2007 | WO2007068894A3 Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease |